BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 30008018)

  • 21. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
    Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
    PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lipidomics meets cardiac magnetic resonance imaging: profiling of subjects at risk of dilated cardiomyopathy.
    Sysi-Aho M; Koikkalainen J; Seppänen-Laakso T; Kaartinen M; Kuusisto J; Peuhkurinen K; Kärkkäinen S; Antila M; Lauerma K; Reissell E; Jurkko R; Lötjönen J; Heliö T; Orešič M
    PLoS One; 2011 Jan; 6(1):e15744. PubMed ID: 21283746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel mutations in LMNA associated with familial forms of dilated cardiomyopathy.
    Stallmeyer B; Koopmann M; Schulze-Bahr E
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):543-9. PubMed ID: 22224630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.
    van Rijsingen IA; Bakker A; Azim D; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Christiaans I; Lekanne Dit Deprez RH; Wilde AA; Zwinderman AH; Meijers JC; Grootemaat AE; Nieuwland R; Pinto YM; Pinto-Sietsma SJ
    Int J Cardiol; 2013 Sep; 168(1):472-7. PubMed ID: 23073275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of plasma miRNA biomarker signature panel for the detection of early HIV-1 infection.
    Biswas S; Haleyurgirisetty M; Lee S; Hewlett I; Devadas K
    EBioMedicine; 2019 May; 43():307-316. PubMed ID: 31005516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating microRNA signature for the diagnosis of childhood dilated cardiomyopathy.
    Jiao M; You HZ; Yang XY; Yuan H; Li YL; Liu WX; Jin M; Du J
    Sci Rep; 2018 Jan; 8(1):724. PubMed ID: 29335596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists.
    Garabet L; Ghanima W; Rangberg A; Teruel-Montoya R; Martinez C; Lozano ML; Nystrand CF; Bussel JB; Sandset PM; Jonassen CM
    Platelets; 2020; 31(2):198-205. PubMed ID: 30885035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.
    Taylor MR; Fain PR; Sinagra G; Robinson ML; Robertson AD; Carniel E; Di Lenarda A; Bohlmeyer TJ; Ferguson DA; Brodsky GL; Boucek MM; Lascor J; Moss AC; Li WL; Stetler GL; Muntoni F; Bristow MR; Mestroni L;
    J Am Coll Cardiol; 2003 Mar; 41(5):771-80. PubMed ID: 12628721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation.
    Hasselberg NE; Haland TF; Saberniak J; Brekke PH; Berge KE; Leren TP; Edvardsen T; Haugaa KH
    Eur Heart J; 2018 Mar; 39(10):853-860. PubMed ID: 29095976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
    J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy.
    Perrot A; Hussein S; Ruppert V; Schmidt HH; Wehnert MS; Duong NT; Posch MG; Panek A; Dietz R; Kindermann I; Böhm M; Michalewska-Wludarczyk A; Richter A; Maisch B; Pankuweit S; Ozcelik C
    Basic Res Cardiol; 2009 Jan; 104(1):90-9. PubMed ID: 18795223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease.
    Arbustini E; Pilotto A; Repetto A; Grasso M; Negri A; Diegoli M; Campana C; Scelsi L; Baldini E; Gavazzi A; Tavazzi L
    J Am Coll Cardiol; 2002 Mar; 39(6):981-90. PubMed ID: 11897440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy.
    Cheng X; Jian D; Xing J; Liu C; Liu Y; Cui C; Li Z; Wang S; Li R; Ma X; Wang Y; Gu X; Ge Z; Tang H; Liu L
    Clin Transl Med; 2023 May; 13(5):e1258. PubMed ID: 37138538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Genetic Determination of the Differentiation Between Ischemic Dilated Cardiomyopathy and Idiopathic Dilated Cardiomyopathy.
    Onrat ST; Onrat E; Ercan Onay E; Yalım Z; Avşar A
    Genet Test Mol Biomarkers; 2018 Nov; 22(11):644-651. PubMed ID: 30346833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Exosomal MiR-92b-5p as a Potential Biomarker for Acute Heart Failure Caused by Dilated Cardiomyopathy.
    Wu T; Chen Y; Du Y; Tao J; Zhou Z; Yang Z
    Cell Physiol Biochem; 2018; 46(5):1939-1950. PubMed ID: 29719295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.